Christopher Maisel is an Oncology physician affiliated with Baylor University Medical Center. OpenAlex indexes 41 publications with 418 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3410 Worth St
Dallas, TX 752462003
Telephone
214-370-1000Registry record last updated 1 Sept 2011.
Industry payments
49 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year20259 payments$23,090openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202513 payments$11,914openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
42.9%CD38-directed Cytolytic Antibody38.9%Daratumumab100%Part B, office-administered≥11 patientsKinase inhibitor1.8%Brukinsa47%Jakafi24%Calquence17%Imbruvica12%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
39.1%Other antiemetics34.1%Fosaprepitant100%Part B, office-administered≥17 patientsSerotonin-3 Receptor Antagonist4.8%Palonosetron hcl56%Granisetron hydrochloride40%Ondansetron Hcl4%Part D + Part B<11 patients+ 1 more class in this area
Anti-infectives
8%Human Immunoglobulin G7.4%Immune globulin100%Part B, office-administered≥11 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.6%Valacyclovir100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Grayburn, MD
Baylor University Medical Center
Stuart Spechler, MD
Baylor University Medical Center
Brooks Cash, MD
Baylor University Medical Center
Robert Perrillo, MD
Baylor University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”